Monitoring Outcomes of Psychiatric Pharmacotherapy

Recruiting

• Conditions: psychiatric diseases; 10037176

• Registration Number: NL-OMON56043
• Lead Sponsor: GGZ Drenthe

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 23 April 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 10000

Inclusion Criteria

• Visiting an outpatient department of a participating mental health center
(first time or follow-up visit);
• Older than 18 years of age;
• Signed informed consent;

Exclusion Criteria

None

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The efficacy, (cost)effectiveness and safety of psychiatric pharmacotherapy<br /><br>(after implementation of a monitoring programme):<br /><br>- monitoring outcomes, such as antropometric examinations, blood parameters,<br /><br>etc.<br /><br>- score on psychiatric questionnaires<br /><br>- patient characteristics such as pharmacogenetics or biomarker levels<br /><br>- medication usage<br /><br>Specific primary and secondary study parameters will be determined for each<br /><br>individual research question. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>For example time (e.g. duration of psychotropic drug usage, duration of<br /><br>treatment at the outpatient department), costs, medication adherence, etc. </p><br>